Company Filing History:
1 out of 93 
1 out of 1,500 
Years Active: 2006
Title: William Michne: Innovator in Neurological Treatments
Introduction
William Michne is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurological diseases and disorders. His work has the potential to impact the treatment of various neurological conditions.
Latest Patents
William Michne holds 1 patent for his invention titled "Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists." This patent provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors. These compounds are useful for treating neurological diseases and disorders, and the patent also discloses methods for preparing these compounds.
Career Highlights
Throughout his career, Michne has worked with prominent companies in the pharmaceutical industry, including NPS Pharmaceuticals, Inc. and AstraZeneca AB. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.
Collaborations
William Michne has collaborated with notable colleagues such as Bradford Van Wagenen and Thomas M Stormann. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
William Michne's contributions to the field of pharmaceuticals, particularly in the area of neurological treatments, highlight his innovative spirit and dedication to improving healthcare. His patent for heteropolycyclic compounds represents a significant step forward in the search for effective treatments for neurological disorders.